A recent
report published by Infinium Global Research on the psoriasis therapeutics market
provides an in-depth analysis of segments and sub-segments in the global as well
as regional psoriasis therapeutics market. The study also highlights the impact
of drivers, restraints, and macro indicators on the global and regional
psoriasis therapeutics market over the short term as well as long term. The
report is a comprehensive presentation of trends, forecasts, and dollar values of the global psoriasis therapeutics market. According to the report, the global
psoriasis therapeutics market is projected to grow at a CAGR of 9% over the
forecast period of 2022-2028. The revenue generated by the psoriasis therapeutics market was approximately USD 24 billion in 2022 and is expected to reach approximately USD 44
billion in 2028.
Market
Insight
The
psoriasis therapeutics market is projected to register with a CAGR of 9% during the
forecast period. Psoriasis is a chronic inflammatory skin condition that is
often connected with our systematic manifestation. This genetic condition may
or may not be present at birth, but genetic and environmental factors could
also trigger it. Psoriasis is a non-contagious autoimmune skin disease
characterized by red scaly patches forming on the affected area. This condition
causes skin cells to grow fast and cause a rapid build-up of thick scaly
patches on the surface of the skin. Moreover, the skin cells' cycle is
disturbed, due to which new cells under the skin grow and surface quickly to
form itchy patches known as "plaques". Symptoms worsen during the
winter season, and sufferers can experience allergic reactions to medicines,
infections, or even psychological stress. Diagnosis of psoriasis is typically
based on signs and symptoms. Generally, it was thought to be a genetic disease
triggered by pollution. The etiology of this disease is unknown; however, it is
said that overactivity of the immune system can cause widespread inflammation,
thereby resulting in the flaking of skin and forming red, white, or silvery
patches. However, the unknown etiology of this disease is the major factor
hampering the growth of the market. n addition, government initiatives for
research and development (R&D) of the disease and cures, and favorable
reimbursement policies will further fuel the growth of this market over the
forecast period.
COVID-19 was
an incomparable global public health emergency that has affected almost every
industry and is projected to impact these various industry growths during the
forecast period. During the Covid-19, pandemic people were compelled to stay in
their homes. The governments of many countries in the world turned their focus
to healthcare from other industries. The epidemic has positively affected the
global psoriasis therapeutics market. The global COVID-19 pandemic has been
unprecedented and staggering, with psoriasis treatment experiencing
higher-than-anticipated demand across all regions compared to pre-pandemic
levels. The significant growth was due to an increase in key players' revenues,
higher demand for psoriasis treatment, increasing investment in research &
development of new drugs, and others.
A skin
disorder that is considered mainly by skin irritation and scaly rashes where
the skin cells multiply up to 10 times faster than normal, such disorder is
known as psoriasis. Psoriasis varies in rigorousness from small, localized
patches to complete body coverage. The body parts such as knees, elbows, and
scalp are major get affected by psoriasis. The therapy for this disease is to
stop the skin cells from developing so quickly. The therapeutic approach for
psoriasis depends upon the amount of skin affected by this disorder. Radiation
therapy in severe cases is used to treat psoriasis. Topical treatments,
injecting steroids, and internal medicine are other treatment methods for
psoriasis. The demand for psoriasis therapeutics is increasing worldwide, due
to the rising incidence of psoriasis with skin disorders. In addition,
increasing awareness among people relating to different treatments available in
the market is likely to boost the growth of the market. On the other hand, high
costs of therapies are likely to hamper the growth of the market. Furthermore,
the cumulative development of new biologics and new pipeline drugs will bring
more opportunities to this market.
The report
provides a regional outlook covering geographies such as North America, Europe,
Asia-Pacific, and the Rest of the World. North America holds the command over
the global psoriasis therapeutics market and is expected to dominate the
overall market during the forecast period. The rising burden of this condition
in the region and increasing initiatives to raise awareness among the general
population are anticipated to boost the demand for effective treatment options
for managing the condition. For instance, every year in August, Psoriasis
Awareness Month is organized in the U.S. to educate and inform patients about
the diagnosis and treatment options for this disorder. The region is expected
to maintain its dominance during the forecast period. The dominance is
attributed to the higher adoption of advanced treatment therapies, increasing
research and development spending by the players in the region on clinical
trials for psoriasis treatment, and increasing long-term & preventive
healthcare facilities. Europe and the Asia Pacific are followed next after
North America owing to the presence of a diversified patient pool, emerging
economies, and a rise in the collaboration of domestic and international
companies in these regions, thus driving this market.

Segment
Covered
The report
on the global psoriasis therapeutics market covers segments such as molecule type,
route of administration, and dosage. On the basis of molecule type, the
sub-markets include biologics and small molecules. On the basis of route of
administration, the sub-markets include oral, parenteral, and topical. On the
basis of dosage, the sub-markets include TNF inhibitors, pde4 inhibitors,
interleukin blockers, and others.
Companies
Profiled:
The report
provides profiles of the companies in the market such as Astellas Pharma Inc.,
AstraZeneca plc, Boehringer Ingelheim GmbH, F. Hofffmann-La Roche,
GlaxoSmithKline plc, Merck and Co., Inc., Valeant Pharmaceuticals
International, Inc., Biocon Limited, Eli Lilly and Company, and G and W
Laboratories Inc.
Report
Highlights:
The report
provides deep insights into the demand forecasts, market trends, and micro and
macro indicators. In addition, this report provides insights into the factors driving and restraining this market's growth. Moreover, The
IGR-Growth Matrix analysis given in the report brings an insight into the
investment areas that existing or new market players can consider. The report
provides insights into the market using analytical tools such as Porter's five
forces analysis and DRO analysis of the psoriasis therapeutics market. Moreover,
the study highlights current market trends and provides forecasts for
2022-2028. We also have highlighted future trends in the market that will
affect the demand during the forecast period. Moreover, the competitive
analysis given in each regional market brings an insight into the market share
of the leading players.